Patent Law Weblog
recent posts
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs – Part II
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
about
Month: March 2013
-
The "Obvious to Try" Test Is Overused in Assessing Obviousness The UK Court of Appeal Decision in Novartis AG vs Generics (UK) Ltd (trading as Mylan), provides insight into the UK court's approach to judging the validity of patents relating to enantiomers of biologically active compounds. UK Patent No. 2,203,040 to Novartis AG (and the…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Millennium Pharmaceuticals Inc. v. Fresenius Kabi USA LLC et al.1:13-cv-00467; filed March 22, 2013 in the District Court of Delaware • Plaintiff: Millennium Pharmaceuticals Inc.• Defendants: Fresenius Kabi USA LLC; Fresenius Kabi USA Inc.; Fresenius…
-
April 3-5, 2013 – 28th Annual Intellectual Property Law Conference (American Bar Association (ABA) Section of Intellectual Property Law) – Arlington, VA April 4, 2013 – Inter Partes Review: A 6-Month Check-up (Intellectual Property Owners Association) – 2:00 – 3:00 pm (ET) April 4, 2013 – Double Patenting: Defeating Rejections and Avoiding Terminal Disclaimers (Strafford)…
-
CPS, an ad hoc non-profit association of senior corporate patent professionals dedicated to the effective and healthy exchange of ideas and experiences in the area of intellectual property law and corporate practice, will be holding the 48th annual Corporate Patent Seminar on April 17-19, 2013 at the Amalfi Hotel in Chicago, IL. The Corporate Patent…
-
D Young & Co will be offering its next European biotech patent law update on April 17, 2013. The 45-minute webinar will be offered at three times: 4:00 am, 7:00 am, 12:00 pm (EDT). Robert Dempster and Simon O'Brien will provide an essential update on European biotechnology case law and live Q&A on EPO biotechnology…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Inter Partes Review: A 6-Month Check-up" on April 4, 2013 beginning at 2:00 pm (ET). A panel consisting of Jason Mudd of Erise IP, Matthew Smith of Foley & Lardner LLP, and Jeanne Suchodolski of Intellectual Ventures will analyze the Patent Trial and…
-
The Loyola University Chicago Law Journal will be holding a conference entitled "Patents, Innovation, and Freedom to Use Ideas" on April 11, 2013 at the Philip H. Corboy Law Center in Chicago, IL. The conference will consist of the following sessions: • Questioning the Assumptions of the Patent System;• What Can We Learn from Creators?•…
-
By Kevin E. Noonan — Paul Bender, former Clinton-era Principal Deputy Solicitor General, and his colleagues Christopher A. Mohr and Michael Kippler at the University of Arizona Law School, published a White Paper entitled "S. 214's inappropriate interference With the Fundamental Right to Settle Litigation" on Monday, March 25, the very same day that the…
-
By Todd Shand — On 15 March 2013, the Australian Federal Court upheld Eli Lilly's patent for the active compound in their highly successful product ZYPREXA®. Lilly successfully defended the validity of the patent against a wide-ranging attack by the well-known generic pharmaceutical manufacturer Apotex. Wrays is pleased to have been able to work together…
-
By Kevin E. Noonan — The U.S. Supreme Court will hear arguments in Association for Molecular Pathology v. Myriad Genetics, Inc. on April 15th, and the parties and their different cadres of amici have submitted briefs of varying degrees of helpfulness and coherence to the Court. In reviewing these briefs, and the Mayo Collaborative Services…
Patent Docs 